Clinical Cancer Research Grants Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chow, H-H. S.
Right arrow Articles by Alberts, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chow, H-H. S.
Right arrow Articles by Alberts, D. S.
Clinical Cancer Research Vol. 9, 3312-3319, August 2003
© 2003 American Association for Cancer Research


Clinical Trials

Pharmacokinetics and Safety of Green Tea Polyphenols after Multiple-Dose Administration of Epigallocatechin Gallate and Polyphenon E in Healthy Individuals1

H-H. Sherry Chow2, Yan Cai, Iman A. Hakim, James A. Crowell, Farah Shahi, Chris A. Brooks, Robert T. Dorr, Yukihiko Hara and David S. Alberts

Arizona Cancer Center, The University of Arizona, Tucson, Arizona 85724 [H-H. S. C., Y. C., I. A. H., F. S., C. A. B., R. T. D., D. S. A.]; College of Pharmacy, The University of Arizona, Tucson, Arizona 85721 [H-H. S. C., Y. C.]; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892 [J. A. C.]; and Mitsui Norin Co., Ltd., Shizuoka 426-01, Japan [Y. H.]

Purpose: Green tea and green tea polyphenols have been shown to possess cancer preventive activities in preclinical model systems. In preparation for future green tea intervention trials, we have conducted a clinical study to determine the safety and pharmacokinetics of green tea polyphenols after 4 weeks of daily p.o. administration of epigallocatechin gallate (EGCG) or Polyphenon E (a defined, decaffeinated green tea polyphenol mixture). In an exploratory fashion, we have also determined the effect of chronic green tea polyphenol administration on UV-induced erythema response.

Experimental Design: Healthy participants with Fitzpatric skin type II or III underwent a 2-week run-in period and were randomly assigned to receive one of the five treatments for 4 weeks: 800 mg EGCG once/day, 400 mg EGCG twice/day, 800 mg EGCG as Polyphenon E once/day, 400 mg EGCG as Polyphenon E twice/day, or a placebo once/day (8 subjects/group). Samples were collected and measurements performed before and after the 4-week treatment period for determination of safety, pharmacokinetics, and biological activity of green tea polyphenol treatment.

Results: Adverse events reported during the 4-week treatment period include excess gas, upset stomach, nausea, heartburn, stomach ache, abdominal pain, dizziness, headache, and muscle pain. All of the reported events were rated as mild events. For most events, the incidence reported in the polyphenol-treated groups was not more than that reported in the placebo group. No significant changes were observed in blood counts and blood chemistry profiles after repeated administration of green tea polyphenol products. There was a >60% increase in the area under the plasma EGCG concentration-time curve after 4 weeks of green tea polyphenol treatment at a dosing schedule of 800 mg once daily. No significant changes were observed in the pharmacokinetics of EGCG after repeated green tea polyphenol treatment at a regimen of 400 mg twice daily. The pharmacokinetics of the conjugated metabolites of epigallocatechin and epicatechin were not affected by repeated green tea polyphenol treatment. Four weeks of green tea polyphenol treatment at the selected dose and dosing schedule did not provide protection against UV-induced erythema.

Conclusions: We conclude that it is safe for healthy individuals to take green tea polyphenol products in amounts equivalent to the EGCG content in 8–16 cups of green tea once a day or in divided doses twice a day for 4 weeks. There is a >60% increase in the systemic availability of free EGCG after chronic green tea polyphenol administration at a high daily bolus dose (800 mg EGCG or Polyphenon E once daily).




This article has been cited by other articles:


Home page
JCOHome page
A.R.M. R. Amin, O. Kucuk, F. R. Khuri, and D. M. Shin
Perspectives for Cancer Prevention With Natural Compounds
J. Clin. Oncol., June 1, 2009; 27(16): 2712 - 2725.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
A. M. Bode and Z. Dong
Epigallocatechin 3-Gallate and Green Tea Catechins: United They Work, Divided They Fail
Cancer Prevention Research, June 1, 2009; 2(6): 514 - 517.
[Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
G. D. Stoner
Foodstuffs for Preventing Cancer: The Preclinical and Clinical Development of Berries
Cancer Prevention Research, March 1, 2009; 2(3): 187 - 194.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. K. Ghosh, N. E. Kay, C. R. Secreto, and T. D. Shanafelt
Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG
Clin. Cancer Res., February 15, 2009; 15(4): 1250 - 1258.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H.-W. Bai and B. T. Zhu
Strong activation of cyclooxygenase I and II catalytic activity by dietary bioflavonoids
J. Lipid Res., December 1, 2008; 49(12): 2557 - 2570.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. W. Laschke, C. Schwender, C. Scheuer, B. Vollmar, and M. D. Menger
Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo
Hum. Reprod., October 1, 2008; 23(10): 2308 - 2318.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Ahmed, H. Marotte, K. Kwan, J. H. Ruth, P. L. Campbell, B. J. Rabquer, A. Pakozdi, and A. E. Koch
Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production
PNAS, September 23, 2008; 105(38): 14692 - 14697.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
I. Papparella, G. Ceolotto, D. Montemurro, M. Antonello, S. Garbisa, G. Rossi, and A. Semplicini
Green Tea Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Rats by Modulating Reactive Oxygen Species Production and the Src/Epidermal Growth Factor Receptor/Akt Signaling Pathway
J. Nutr., September 1, 2008; 138(9): 1596 - 1601.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. W. Anderson, C. Goodin, Y. Zhang, S. Kim, R. D. Estensen, T. S. Wiedmann, P. Sekar, C. R. Buncher, J. C. Khoury, J. R. Garbow, et al.
Effect of dietary green tea extract and aerosolized difluoromethylornithine during lung tumor progression in A/J strain mice
Carcinogenesis, August 1, 2008; 29(8): 1594 - 1600.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Lu, H. Xiao, H. You, Y. Lin, H. Jin, B. Snagaski, and C. S. Yang
Synergistic Inhibition of Lung Tumorigenesis by a Combination of Green Tea Polyphenols and Atorvastatin
Clin. Cancer Res., August 1, 2008; 14(15): 4981 - 4988.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. M. Henning, J. J. Choo, and D. Heber
Nongallated Compared with Gallated Flavan-3-ols in Green and Black Tea Are More Bioavailable
J. Nutr., August 1, 2008; 138(8): 1529S - 1534S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Auger, W. Mullen, Y. Hara, and A. Crozier
Bioavailability of Polyphenon E Flavan-3-ols in Humans with an Ileostomy
J. Nutr., August 1, 2008; 138(8): 1535S - 1542S.
[Abstract] [Full Text] [PDF]


Home page
Bioscience HorizonsHome page
S. Brierley-Hobson
Binding of (-)-epigallocatechin-3-gallate to the Hsp70 ATPase domain may promote apoptosis in colorectal cancer
Bioscience Horizons, March 1, 2008; 1(1): 9 - 18.
[Abstract] [Full Text] [PDF]


Home page
Food Science and Technology InternationalHome page
J. Wang, B. Wang, W. Jiang, and Y. Zhao
Quality and Shelf Life of Mango (Mangifera Indica L. cv. `Tainong') Coated by Using Chitosan and Polyphenols
Food Science and Technology International, August 1, 2007; 13(4): 317 - 322.
[Abstract] [PDF]


Home page
J. Am. Coll. Nutr.Home page
D. L. McKay and J. B. Blumberg
Roles for Epigallocatechin Gallate in Cardiovascular Disease and Obesity: An Introduction
J. Am. Coll. Nutr., August 1, 2007; 26(4): 362S - 365S.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
J. R. Carlson, B. A. Bauer, A. Vincent, P. J. Limburg, and T. Wilson
Reading the Tea Leaves: Anticarcinogenic Properties of (-)-Epigallocatechin-3-Gallate
Mayo Clin. Proc., June 1, 2007; 82(6): 725 - 732.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H. Shapiro, P. Singer, Z. Halpern, and R. Bruck
Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis
Gut, March 1, 2007; 56(3): 426 - 436.
[Full Text] [PDF]


Home page
J. Nutr.Home page
B. Wessner, E.-M. Strasser, N. Koitz, C. Schmuckenschlager, N. Unger-Manhart, and E. Roth
Green Tea Polyphenol Administration Partly Ameliorates Chemotherapy-Induced Side Effects in the Small Intestine of Mice
J. Nutr., March 1, 2007; 137(3): 634 - 640.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
S. Mirkov, B. J. Komoroski, J. Ramirez, A. Y. Graber, M. J. Ratain, S. C. Strom, and F. Innocenti
Effects of Green Tea Compounds on Irinotecan Metabolism
Drug Metab. Dispos., February 1, 2007; 35(2): 228 - 233.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. H. Kang, J. H. Lee, C. K. Song, H. D. Han, B. C. Shin, S. I. Pai, C.-F. Hung, C. Trimble, J.-S. Lim, T. W. Kim, et al.
Epigallocatechin-3-Gallate Enhances CD8+ T Cell-Mediated Antitumor Immunity Induced by DNA Vaccination
Cancer Res., January 15, 2007; 67(2): 802 - 811.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H-H. S. Chow, I. A. Hakim, D. R. Vining, J. A. Crowell, C. A. Cordova, W. M. Chew, M.-J. Xu, C.-H. Hsu, J. Ranger-Moore, and D. S. Alberts
Effects of Repeated Green Tea Catechin Administration on Human Cytochrome P450 Activity
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2473 - 2476.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Lu, J. Liao, G. Yang, K. R. Reuhl, X. Hao, and C. S. Yang
Inhibition of Adenoma Progression to Adenocarcinoma in a 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone-Induced Lung Tumorigenesis Model in A/J Mice by Tea Polyphenols and Caffeine
Cancer Res., December 1, 2006; 66(23): 11494 - 11501.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. A. Shammas, P. Neri, H. Koley, R. B. Batchu, R. C. Bertheau, V. Munshi, R. Prabhala, M. Fulciniti, Y. t. Tai, S. P. Treon, et al.
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications
Blood, October 15, 2006; 108(8): 2804 - 2810.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
F. Spinella, L. Rosano, V. Di Castro, S. Decandia, A. Albini, M. R. Nicotra, P. G. Natali, and A. Bagnato
Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
Mol. Cancer Ther., June 1, 2006; 5(6): 1483 - 1492.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Kim, X. Zhang, K. M. Rieger-Christ, I. C. Summerhayes, D. E. Wazer, K. E. Paulson, and A. S. Yee
Suppression of Wnt Signaling by the Green Tea Compound (-)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer Cells: REQUIREMENT OF THE TRANSCRIPTIONAL REPRESSOR HBP1
J. Biol. Chem., April 21, 2006; 281(16): 10865 - 10875.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Dormeyer, Y. Adams, B. Kramer, S. Chakravorty, M. T. Tse, S. Pegoraro, L. Whittaker, M. Lanzer, and A. Craig
Rational Design of Anticytoadherence Inhibitors for Plasmodium falciparum Based on the Crystal Structure of Human Intercellular Adhesion Molecule 1
Antimicrob. Agents Chemother., February 1, 2006; 50(2): 724 - 730.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. D. Stapleton, S. Shah, Y. Hara, and P. W. Taylor
Potentiation of Catechin Gallate-Mediated Sensitization of Staphylococcus aureus to Oxacillin by Nongalloylated Catechins
Antimicrob. Agents Chemother., February 1, 2006; 50(2): 752 - 755.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Bettuzzi, M. Brausi, F. Rizzi, G. Castagnetti, G. Peracchia, and A. Corti
Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins in Volunteers with High-Grade Prostate Intraepithelial Neoplasia: A Preliminary Report from a One-Year Proof-of-Principle Study
Cancer Res., January 15, 2006; 66(2): 1234 - 1240.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-i. Suzuki, M. Ogawa, Y. M. Sagesaka, and M. Isobe
Tea catechins attenuate ventricular remodeling and graft arterial diseases in murine cardiac allografts
Cardiovasc Res, January 1, 2006; 69(1): 272 - 279.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. F. McCarty and K. I. Block
Multifocal Angiostatic Therapy: An Update
Integr Cancer Ther, December 1, 2005; 4(4): 301 - 314.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
K. Rezai-Zadeh, D. Shytle, N. Sun, T. Mori, H. Hou, D. Jeanniton, J. Ehrhart, K. Townsend, J. Zeng, D. Morgan, et al.
Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice
J. Neurosci., September 21, 2005; 25(38): 8807 - 8814.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
B. Min, B. F. McBride, M. J. Kardas, A. Ismali, V. Sinha, J. Kluger, and C. M. White
Hemodynamic impact of an ephedra-free multicomponent weight-loss supplement
Am. J. Health Syst. Pharm., August 1, 2005; 62(15): 1582 - 1585.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H-H. S. Chow, I. A. Hakim, D. R. Vining, J. A. Crowell, J. Ranger-Moore, W. M. Chew, C. A. Celaya, S. R. Rodney, Y. Hara, and D. S. Alberts
Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single-Dose Administration of Polyphenon E in Healthy Individuals
Clin. Cancer Res., June 15, 2005; 11(12): 4627 - 4633.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Shimizu, A. Deguchi, J. T.E. Lim, H. Moriwaki, L. Kopelovich, and I. B. Weinstein
(-)-Epigallocatechin Gallate and Polyphenon E Inhibit Growth and Activation of the Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor-2 Signaling Pathways in Human Colon Cancer Cells
Clin. Cancer Res., April 1, 2005; 11(7): 2735 - 2746.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. M Henning, Y. Niu, N. H Lee, G. D Thames, R. R Minutti, H. Wang, V. L. W Go, and D. Heber
Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1558 - 1564.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Fassina, R. Vene, M. Morini, S. Minghelli, R. Benelli, D. M. Noonan, and A. Albini
Mechanisms of Inhibition of Tumor Angiogenesis and Vascular Tumor Growth by Epigallocatechin-3-Gallate
Clin. Cancer Res., July 15, 2004; 10(14): 4865 - 4873.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Nagai, A. H. Conney, and B. T. Zhu
STRONG INHIBITORY EFFECTS OF COMMON TEA CATECHINS AND BIOFLAVONOIDS ON THE O-METHYLATION OF CATECHOL ESTROGENS CATALYZED BY HUMAN LIVER CYTOSOLIC CATECHOL-O-METHYLTRANSFERASE
Drug Metab. Dispos., May 1, 2004; 32(5): 497 - 504.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. S. Wheeler, J. D. Catravas, K. Odoms, A. Denenberg, V. Malhotra, and H. R. Wong
Epigallocatechin-3-gallate, a Green Tea-Derived Polyphenol, Inhibits IL-1{beta}-Dependent Proinflammatory Signal Transduction in Cultured Respiratory Epithelial Cells
J. Nutr., May 1, 2004; 134(5): 1039 - 1044.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.